Nothing Special   »   [go: up one dir, main page]

SE9403389D0 - Pharmaceutical composition containing derivatives of sex hormones - Google Patents

Pharmaceutical composition containing derivatives of sex hormones

Info

Publication number
SE9403389D0
SE9403389D0 SE9403389A SE9403389A SE9403389D0 SE 9403389 D0 SE9403389 D0 SE 9403389D0 SE 9403389 A SE9403389 A SE 9403389A SE 9403389 A SE9403389 A SE 9403389A SE 9403389 D0 SE9403389 D0 SE 9403389D0
Authority
SE
Sweden
Prior art keywords
pharmaceutical composition
composition containing
sex hormones
containing derivatives
derivatives
Prior art date
Application number
SE9403389A
Other languages
Swedish (sv)
Inventor
Stefan Friess
Harald Heckenmueller
Heike Kublik
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9403389A priority Critical patent/SE9403389D0/en
Publication of SE9403389D0 publication Critical patent/SE9403389D0/en
Priority to AU36904/95A priority patent/AU3690495A/en
Priority to PCT/SE1995/001102 priority patent/WO1996010991A1/en

Links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

A pharmaceutical composition having a form suitable for transmucosal administration containing 17 beta -estradiol and a compound selected from the progestins as active ingredients.
SE9403389A 1994-10-06 1994-10-06 Pharmaceutical composition containing derivatives of sex hormones SE9403389D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9403389A SE9403389D0 (en) 1994-10-06 1994-10-06 Pharmaceutical composition containing derivatives of sex hormones
AU36904/95A AU3690495A (en) 1994-10-06 1995-09-27 Pharmaceutical composition containing derivatives of sex hormones
PCT/SE1995/001102 WO1996010991A1 (en) 1994-10-06 1995-09-27 Pharmaceutical composition containing derivatives of sex hormones

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9403389A SE9403389D0 (en) 1994-10-06 1994-10-06 Pharmaceutical composition containing derivatives of sex hormones

Publications (1)

Publication Number Publication Date
SE9403389D0 true SE9403389D0 (en) 1994-10-06

Family

ID=20395505

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9403389A SE9403389D0 (en) 1994-10-06 1994-10-06 Pharmaceutical composition containing derivatives of sex hormones

Country Status (3)

Country Link
AU (1) AU3690495A (en)
SE (1) SE9403389D0 (en)
WO (1) WO1996010991A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754179B1 (en) 1996-10-08 1998-12-24 Theramex NOVEL HORMONONAL COMPOSITION AND ITS USE
FR2779062A1 (en) * 1998-06-02 1999-12-03 Investigations Therapeutiques Composition for treating menopause and post-menopause symptoms
GB9823246D0 (en) * 1998-10-24 1998-12-16 Danbiosyst Uk A nasal drug delivery composition
WO2001030356A1 (en) 1999-10-25 2001-05-03 Laboratoire Theramex Hormonal composition based on a progestational agent and an oestrogen and use thereof
US20030108964A1 (en) * 2000-03-02 2003-06-12 Andrea Leblanc Caspase-inhibitory-factor(cif)and uses thereof
EP1462106A1 (en) * 2003-03-28 2004-09-29 Pantarhei Bioscience B.V. Pharmaceutical compositions and kits comprising 17-beta-estradiol and a progesteron for the treatment of gynecological disorders
DE60323725D1 (en) * 2003-03-28 2008-11-06 Pantarhei Bioscience Bv Female contraceptive method and pharmaceutical preparations suitable for such method
CA2581932A1 (en) * 2004-09-27 2006-04-06 Pantarhei Bioscience B.V. A method of female contraception and a kit for use therein
UY33103A (en) * 2009-12-15 2011-07-29 Techsphere S A De C V PARENTERAL PHARMACEUTICAL FORMULATION IN SUSPENSION, SUSTAINED RELEASE, IN LOW AND ULTRA LOW DOSE, IN HORMONAL THERAPY IN THE CLIMATE SYNDROME
TW201138782A (en) 2010-04-26 2011-11-16 Besins Healthcare Lu Sarl Low-oil pharmaceutical emulsion compositions comprising progestogen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU614465B2 (en) * 1989-04-05 1991-08-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
EP0461290B1 (en) * 1990-06-14 1994-01-12 HENNING BERLIN GmbH CHEMIE- UND PHARMAWERK Capsules with a liquid content
SE9301171D0 (en) * 1993-04-07 1993-04-07 Ab Astra PHARMACEUTICAL COMPOSITION CONTAINING LIPOPHILIC DRUGS

Also Published As

Publication number Publication date
WO1996010991A1 (en) 1996-04-18
AU3690495A (en) 1996-05-02

Similar Documents

Publication Publication Date Title
SE8300736D0 (en) NOVEL PHARMACOLOGICALLY ACTIVE COMPOUNDS
MY101791A (en) New benzimidazole derivatives
IT1255258B (en) PHARMACEUTICAL COMPOSITIONS FOR THE NASAL APPLICATION.
OA09772A (en) "mometasone furoate monohydrate, process for making same and pharmaceutical compositions".
SE9301171D0 (en) PHARMACEUTICAL COMPOSITION CONTAINING LIPOPHILIC DRUGS
BG60102B2 (en) Method for preparing of 5-fluoro-2[[(4-cyclopropylmethoxy-2-pyridyl)methyl]thionyl]-1h-ben zimidazole
BR9810495A (en) Pharmaceutical composition
KR890700125A (en) New benzimidazole derivatives, preparation method thereof and pharmaceutical composition containing the compound
TR199801861T2 (en) Pharmaceutically useful compositions.
CA2270177A1 (en) Transdermal administration of ment
RS50046B (en) PHARMACEUTICAL COMPOSITIONS OF TIZOXANIDE AND NITAZOXANIDE
SE8404065D0 (en) NOVEL BIOLOGICALLY ACTIVE COMPOUNDS
SE9403389D0 (en) Pharmaceutical composition containing derivatives of sex hormones
PT975348E (en) STABILIZED TIBOLONE COMPOSITIONS
ATE215817T1 (en) SOLID DRUGS CONTAINING MILTEFOSINE FOR ORAL ADMINISTRATION IN THE TREATMENT OF LEISHMANIASIS
SE8804628D0 (en) NEW COMPOUNDS
MX9708394A (en) Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation.
CA2348474A1 (en) Pharmaceutically active composition and dispensing device
ES2060293T3 (en) NEW ANTI-ULCER SUBSTANCE.
MX9709453A (en) Oral pharmaceutical composition of piperidinoalkanol compounds in solution form.
FI923751A (en) HEXAHYDROBENSO / F / KINOLINONER
EP0348664A3 (en) Pharmaceutical compositions containing monoacetoacetins for treating tumours
ATE102934T1 (en) FLUORINATED FLAVONACETIC ACID.
ATE224716T1 (en) PHARMACEUTICAL COMPOSITIONS OF CINCHONINE DIHYDROCHLORIDE
DE69614552D1 (en) MODIFIED ALPHA-D-GLCP- (1,2) -ALPHA-D-Glcp- (1,3) -ALPHA-D-Glcp ANALOGS